New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

CRISPR Could Eliminate Human Pain

Scientists have identified a string of genetic code that functions as a volume knob for human suffering, and pharmaceutical firms are working to mimic the effects.

Painless Index / Image: Alyssa Foote
Painless Index / Image: Alyssa Foote

A recent Wired article discussed the concept of gene editing to eliminate pain. There’s a rare group of people who experience pain insensitivity, and their DNA could unlock the key to eliminating not just pain, but also anxiety from the human condition. However, the idea raises ethical issues. If a person is unable to experience pain and anxiety, does it affect their moral compass? Could gene editing be used to create super-soldiers?

While it’s certainly unpleasant, the human body evolved to feel pain as a way to notify a person that something is wrong with their body. One reason pioneers in gene-based pain therapy aren’t using CRISPR yet is that it’s permanent. Rather, companies are focusing on treating pain by engineering receptors in people’s sensory neurons that can be controlled by a small molecule drug in a virus. A one-time injection delivers instructions for creating a “tunable on/off switch.” This means that when a patient feels pain, they can take the drug to shut down pain perception without full-body side effects of risk of addiction.

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub